Verrica Pharmaceuticals
VRCA
VRCA
50 hedge funds and large institutions have $29.8M invested in Verrica Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.14% more ownership
Funds ownership: 2.49% → 2.63% (+0.14%)
1% less capital invested
Capital invested by funds: $29.9M → $29.8M (-$158K)
Holders
50
Holding in Top 10
–
Calls
$176K
Puts
$81K
Top Buyers
| 1 | +$361K | |
| 2 | +$355K | |
| 3 | +$138K | |
| 4 |
E
Ergoteles
New York
|
+$97.8K |
| 5 |
Kovitz Investment Group Partners
Chicago,
Illinois
|
+$83K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$535K | |
| 3 | -$422K | |
| 4 |
Renaissance Technologies
New York
|
-$203K |
| 5 |
Morgan Stanley
New York
|
-$80K |